KDR Gene Hemangioma Capillary Infantile Familial Susceptibility NGS Genetic DNA Test
Comprehensive Genetic Assessment for Hereditary Hemangioma Risk
The KDR Gene Hemangioma Capillary Infantile Familial Susceptibility NGS Genetic DNA Test represents a cutting-edge approach to understanding genetic predispositions to vascular anomalies. This sophisticated diagnostic tool utilizes next-generation sequencing technology to analyze the KDR (Kinase Insert Domain Receptor) gene, which plays a critical role in vascular development and angiogenesis. Mutations in this gene have been strongly associated with familial susceptibility to capillary infantile hemangiomas, making this test an essential component of comprehensive cancer risk assessment and family health planning.
What Does This Test Measure and Detect?
This advanced genetic test specifically targets and analyzes the complete coding region of the KDR gene using state-of-the-art NGS technology. The test detects:
- Pathogenic variants and mutations in the KDR gene sequence
- Single nucleotide polymorphisms (SNPs) associated with hemangioma susceptibility
- Copy number variations that may impact gene function
- Inherited genetic markers linked to familial hemangioma patterns
- Specific mutations known to increase vascular tumor development risk
Who Should Consider This Genetic Test?
This test is particularly recommended for individuals who present with specific clinical indications or family history patterns:
- Infants or children with multiple or large capillary hemangiomas
- Individuals with a family history of hemangiomas across multiple generations
- Patients with unusual hemangioma presentations or rapid growth patterns
- Families seeking preconception or prenatal genetic counseling
- Individuals with personal history of vascular anomalies seeking comprehensive risk assessment
- Patients with suspected hereditary vascular tumor syndromes
Key Benefits of KDR Genetic Testing
Undergoing this comprehensive genetic assessment provides numerous advantages for patients and healthcare providers:
- Early Risk Identification: Detect genetic susceptibility before clinical symptoms manifest
- Personalized Management: Develop targeted surveillance and intervention strategies
- Family Planning Guidance: Make informed decisions about family health and genetic inheritance
- Proactive Healthcare: Implement preventive measures based on individual genetic risk profiles
- Comprehensive Understanding: Gain insights into the genetic basis of vascular development disorders
- Treatment Optimization: Guide therapeutic approaches based on specific genetic findings
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our team of certified genetic counselors and oncologists. The report typically includes:
- Positive Result: Indicates the presence of pathogenic KDR gene mutations associated with increased hemangioma susceptibility. This finding enables proactive monitoring and early intervention strategies.
- Negative Result: Suggests no detectable mutations in the analyzed KDR gene regions, though does not completely eliminate genetic risk from other factors.
- Variant of Uncertain Significance (VUS): Identifies genetic changes with unclear clinical implications, requiring ongoing research and family studies for interpretation.
All results are accompanied by detailed explanations and recommendations for next steps, including potential follow-up testing, surveillance protocols, and family member testing considerations.
Test Pricing and Availability
| Test Feature | Details |
|---|---|
| Test Name | KDR Gene Hemangioma Capillary Infantile Familial Susceptibility NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible testing for patients nationwide.
Take Control of Your Genetic Health Today
Understanding your genetic predisposition to hemangiomas and vascular anomalies can significantly impact your healthcare journey and family planning decisions. Our team of expert genetic counselors and oncologists is ready to guide you through the testing process and help interpret your results within the context of your personal and family medical history.
Ready to schedule your KDR genetic test? Contact our genetic counseling team today at +1(267) 388-9828 or book your appointment online. Take the first step toward comprehensive genetic risk assessment and personalized healthcare management.
